Clearmind Medicine (CMND) announces that it initiated its Phase I/IIa clinical trial investigating the safety, tolerability and full pharmacokinetic profile of its innovative treatment ...
(RTTNews) - Clearmind Medicine Inc.(CMND), Tuesday announced the initiation of its Phase I/IIa clinical trial to investigate the safety, tolerability, and pharmacokinetics of its innovative drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback